Fulgent Genetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	322.67	283.47	289.21	618.97	992.58
Revenue Growth (YoY)	13.83%	-1.99%	-53.27%	-37.64%	135.37%
Cost of Revenue	191.8	176.26	184.76	252.07	215.53
Gross Profit	130.88	107.22	104.46	366.9	777.05
Selling, General & Admin	160.04	124.35	130.47	149.99	75.17
Depreciation & Amortization Expenses	8.03	7.97	7.85	6.5	1.71
Research & Development	53.91	48.82	41.44	28.91	24.22
Other Operating Expenses	-	-	120.23	2.98	-
Total Operating Expenses	221.97	181.13	299.99	188.37	101.1
Operating Income	-91.1	-73.92	-195.53	178.53	675.95
Interest Income	30.92	31.3	21.61	5.62	-
Interest Expense	-0.08	-0.17	-0.49	-1.01	-
Other Non-Operating Income (Expense)	-9.77	-9.51	0.32	0.89	3.73
Total Non-Operating Income (Expense)	21.07	21.96	21.44	5.5	1.35
Pretax Income	-70.03	-51.96	-174.09	184.03	677.3
Provision for Income Taxes	8.39	8.14	-1.15	-42.1	-174.8
Net Income	-60.51	-42.71	-167.83	143.4	507.36
Minority Interest in Earnings	-1.12	-1.11	-7.41	-1.48	-1.13
Net Income to Common	-60.51	-42.71	-167.83	143.4	507.36
Net Income Growth	-	-	-	-71.74%	136.74%
Shares Outstanding (Basic)	31	30	30	30	29
Shares Outstanding (Diluted)	31	30	30	31	31
Shares Change (YoY)	1.79%	1.51%	-3.81%	-0.04%	28.77%
EPS (Basic)	-1.97	-1.41	-5.63	4.76	17.25
EPS (Diluted)	-1.97	-1.41	-5.63	4.63	16.38
EPS Growth	-	-	-	-71.73%	83.84%
Shares Outstanding	31.08	30.84	29.65	29.44	30.16
Free Cash Flow	-124.21	-19.26	4.8	234.75	514.77
Free Cash Flow Growth	-	-	-97.96%	-54.40%	387.94%
Free Cash Flow Per Share	-4.04	-0.64	0.16	7.58	16.62
Gross Margin	40.56%	37.82%	36.12%	59.28%	78.29%
Operating Margin	-28.23%	-26.08%	-67.61%	28.84%	68.10%
Profit Margin	-19.10%	-15.46%	-60.59%	22.93%	51.00%
FCF Margin	-38.49%	-6.79%	1.66%	37.93%	51.86%
EBITDA	-66.97	-48.99	-169.39	211.19	686.96
EBITDA Margin	-20.76%	-17.28%	-58.57%	34.12%	69.21%
EBIT	-91.1	-73.92	-195.53	178.53	675.95
EBIT Margin	-28.23%	-26.08%	-67.61%	28.84%	68.10%
Effective Tax Rate	-11.99%	-15.66%	0.66%	-22.88%	-25.81%

Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q